{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:50Z","timestamp":1791925670500,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T00:00:00Z","timestamp":1436918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s11481-015-9627-8","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T04:03:37Z","timestamp":1436846617000},"page":"61-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP\/PS1 Mice"],"prefix":"10.1007","volume":"11","author":[{"given":"Angela W.","family":"Corona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Kodoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad T.","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary E.","family":"Landreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,15]]},"reference":[{"key":"9627_CR1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","volume":"12","author":"RJ Bateman","year":"2006","unstructured":"Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM (2006) Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 12:856\u2013861","journal-title":"Nat Med"},{"key":"9627_CR2","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1523\/JNEUROSCI.1729-12.2012","volume":"32","author":"B Cameron","year":"2012","unstructured":"Cameron B, Tse W, Lamb R, Li X, Lamb BT, Landreth GE (2012) Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer\u2019s disease. J Neurosci: OFF J Soc Neurosci 32:15112\u201315123","journal-title":"J Neurosci: OFF J Soc Neurosci"},{"key":"9627_CR3","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C, Goate AM, Bales KR, Paul SM, Bateman RJ, Holtzman DM (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3:89ra57","journal-title":"Sci Transl Med"},{"key":"9627_CR4","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335:1503\u20131506","journal-title":"Science"},{"key":"9627_CR5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","volume":"15","author":"D Nardo De","year":"2014","unstructured":"De Nardo D, Labzin LI, Kono H, Seki R, Schmidt SV, Beyer M, Xu D, Zimmer S, Lahrmann C, Schildberg FA, Vogelhuber J, Kraut M, Ulas T, Kerksiek A, Krebs W, Bode N, Grebe A, Fitzgerald ML, Hernandez NJ, Williams BR, Knolle P, Kneilling M, Rocken M, Lutjohann D, Wright SD, Schultze JL, Latz E (2014) High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol 15:152\u2013160","journal-title":"Nat Immunol"},{"key":"9627_CR6","doi-asserted-by":"crossref","first-page":"34144","DOI":"10.1074\/jbc.M110.108100","volume":"285","author":"JJ Donkin","year":"2010","unstructured":"Donkin JJ, Stukas S, Hirsch-Reinshagen V, Namjoshi D, Wilkinson A, May S, Chan J, Fan J, Collins J, Wellington CL (2010) ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein\/presenilin 1 mice. J Biol Chem 285:34144\u201334154","journal-title":"J Biol Chem"},{"key":"9627_CR7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nm1555","volume":"13","author":"J Khoury El","year":"2007","unstructured":"El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13:432\u2013438","journal-title":"Nat Med"},{"key":"9627_CR8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MR Elmore","year":"2014","unstructured":"Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, Kitazawa M, Matusow B, Nguyen H, West BL, Green KN (2014) Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82:380\u2013397","journal-title":"Neuron"},{"key":"9627_CR9","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","volume":"32","author":"NF Fitz","year":"2012","unstructured":"Fitz NF, Cronican AA, Saleem M, Fauq AH, Chapman R, Lefterov I, Koldamova R (2012) Abca1 deficiency affects Alzheimer\u2019s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J Neurosci: OFF J Soc Neurosci 32:13125\u201313136","journal-title":"J Neurosci: OFF J Soc Neurosci"},{"key":"9627_CR10","doi-asserted-by":"crossref","first-page":"924-c","DOI":"10.1126\/science.1235809","volume":"340","author":"NF Fitz","year":"2013","unstructured":"Fitz NF, Cronican AA, Lefterov I, Koldamova R (2013) Comment on ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 340:924-c","journal-title":"Science"},{"key":"9627_CR11","doi-asserted-by":"crossref","first-page":"41197","DOI":"10.1074\/jbc.M407962200","volume":"279","author":"V Hirsch-Reinshagen","year":"2004","unstructured":"Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH, Cohn JS, Hayden MR, Wellington CL (2004) Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol chem 279:41197\u201341207","journal-title":"J Biol chem"},{"key":"9627_CR12","doi-asserted-by":"crossref","first-page":"43243","DOI":"10.1074\/jbc.M508781200","volume":"280","author":"V Hirsch-Reinshagen","year":"2005","unstructured":"Hirsch-Reinshagen V, Maia LF, Burgess BL, Blain JF, Naus KE, McIsaac SA, Parkinson PF, Chan JY, Tansley GH, Hayden MR, Poirier J, Van Nostrand W, Wellington CL (2005) The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. J Biol Chem 280:43243\u201343256","journal-title":"J Biol Chem"},{"issue":"Pt A","key":"9627_CR13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","volume":"72","author":"DA Hottman","year":"2014","unstructured":"Hottman DA, Chernick D, Cheng S, Wang Z, Li L (2014) HDL and cognition in neurodegenerative disorders. Neurobiol Dis 72(Pt A):22\u201336","journal-title":"Neurobiol Dis"},{"key":"9627_CR14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2015.05.007","volume":"598","author":"A Jan","year":"2015","unstructured":"Jan A, Karasinska JM, Kang MH, de Haan W, Ruddle P, Kaur A, Connolly C, Leavitt BR, Sorensen PH, Hayden MR (2015) Direct intracerebral delivery of a miR-33 antisense oligonucelotide into mouse brain increases brain ABCA1 expression. Neurosci Lett 598:66\u201372","journal-title":"Neurosci Lett"},{"key":"9627_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","volume":"17","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17:157\u2013165","journal-title":"Biomol Eng"},{"key":"9627_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58:681\u2013693","journal-title":"Neuron"},{"key":"9627_CR17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nbd.2013.01.018","volume":"54","author":"JM Karasinska","year":"2013","unstructured":"Karasinska JM, de Haan W, Franciosi S, Ruddle P, Fan J, Kruit JK, Stukas S, Lutjohann D, Gutmann DH, Wellington CL, Hayden MR (2013) ABCA1 influences neuroinflammation and neuronal death. Neurobiol Dis 54:445\u2013455","journal-title":"Neurobiol Dis"},{"key":"9627_CR18","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova R, Staufenbiel M, Lefterov I (2005) Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem 280:43224\u201343235","journal-title":"J Biol Chem"},{"key":"9627_CR19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbalip.2010.02.010","volume":"1801","author":"R Koldamova","year":"2010","unstructured":"Koldamova R, Fitz NF, Lefterov I (2010) The role of ATP-binding cassette transporter A1 in Alzheimer\u2019s disease and neurodegeneration. Biochim Biophys Acta 1801:824\u2013830","journal-title":"Biochim Biophys Acta"},{"key":"9627_CR20","doi-asserted-by":"crossref","first-page":"924-g","DOI":"10.1126\/science.1234114","volume":"340","author":"GE Landreth","year":"2013","unstructured":"Landreth GE, Cramer PE, Lakner MM, Cirrito JR, Wesson DW, Brunden KR, Wilson DA (2013) Response to comments on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340:924-g","journal-title":"Science"},{"key":"9627_CR21","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","volume":"32","author":"S Mandrekar-Colucci","year":"2012","unstructured":"Mandrekar-Colucci S, Karlo JC, Landreth GE (2012) Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer\u2019s disease. J Neurosci Off J Soc Neurosci 32:10117\u201310128","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"9627_CR22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci 13:812\u2013818","journal-title":"Nat Neurosci"},{"key":"9627_CR23","doi-asserted-by":"crossref","first-page":"924-d","DOI":"10.1126\/science.1234089","volume":"340","author":"AR Price","year":"2013","unstructured":"Price AR, Xu G, Siemienski ZB, Smithson LA, Borchelt DR, Golde TE, Felsenstein KM (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340:924-d","journal-title":"Science"},{"key":"9627_CR24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mcn.2007.01.011","volume":"34","author":"DR Riddell","year":"2007","unstructured":"Riddell DR, Zhou H, Comery TA, Kouranova E, Lo CF, Warwick HK, Ring RH, Kirksey Y, Aschmies S, Xu J, Kubek K, Hirst WD, Gonzales C, Chen Y, Murphy E, Leonard S, Vasylyev D, Oganesian A, Martone RL, Pangalos MN, Reinhart PH, Jacobsen JS (2007) The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer\u2019s disease. Mol Cell Neurosci 34:621\u2013628","journal-title":"Mol Cell Neurosci"},{"key":"9627_CR25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/glia.22423","volume":"61","author":"K Saijo","year":"2013","unstructured":"Saijo K, Crotti A, Glass CK (2013) Regulation of microglia activation and deactivation by nuclear receptors. Glia 61:104\u2013111","journal-title":"Glia"},{"key":"9627_CR26","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1523\/JNEUROSCI.4586-14.2015","volume":"35","author":"JC Savage","year":"2015","unstructured":"Savage JC, Jay T, Goduni E, Quigley C, Mariani MM, Malm T, Ransohoff RM, Lamb BT, Landreth GE (2015) Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer\u2019s disease. J Neurosci: OFF J Soc Neurosci 35:6532\u20136543","journal-title":"J Neurosci: OFF J Soc Neurosci"},{"issue":"Pt A","key":"9627_CR27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nbd.2014.05.019","volume":"72","author":"R Skerrett","year":"2014","unstructured":"Skerrett R, Malm T, Landreth G (2014) Nuclear receptors in neurodegenerative diseases. Neurobiol Dis 72(Pt A):104\u2013116","journal-title":"Neurobiol Dis"},{"key":"9627_CR28","doi-asserted-by":"crossref","first-page":"30538","DOI":"10.1074\/jbc.M114.600833","volume":"289","author":"LM Tai","year":"2014","unstructured":"Tai LM, Koster KP, Luo J, Lee SH, Wang YT, Collins NC, Ben Aissa M, Thatcher GR, LaDu MJ (2014) Amyloid-beta Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo. J Biol Chem 289:30538\u201330555","journal-title":"J Biol Chem"},{"key":"9627_CR29","doi-asserted-by":"crossref","first-page":"924-e","DOI":"10.1126\/science.1233937","volume":"340","author":"I Tesseur","year":"2013","unstructured":"Tesseur I, Lo AC, Roberfroid A, Dietvorst S, Van Broeck B, Borgers M, Gijsen H, Moechars D, Mercken M, Kemp J, D\u2019Hooge R, De Strooper B (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340:924-e","journal-title":"Science"},{"key":"9627_CR30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm1781","volume":"14","author":"T Town","year":"2008","unstructured":"Town T, Laouar Y, Pittenger C, Mori T, Szekely CA, Tan J, Duman RS, Flavell RA (2008) Blocking TGF-beta-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med 14:681\u2013687","journal-title":"Nat Med"},{"key":"9627_CR31","doi-asserted-by":"crossref","first-page":"924-f","DOI":"10.1126\/science.1235505","volume":"340","author":"K Veeraraghavalu","year":"2013","unstructured":"Veeraraghavalu K, Zhang C, Miller S, Hefendehl JK, Rajapaksha TW, Ulrich J, Jucker M, Holtzman DM, Tanzi RE, Vassar R, Sisodia SS (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340:924-f","journal-title":"Science"},{"key":"9627_CR32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurol 10:241\u2013252","journal-title":"Lancet Neurol"},{"key":"9627_CR33","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279:40987\u201340993","journal-title":"J Biol Chem"},{"key":"9627_CR34","doi-asserted-by":"crossref","first-page":"43236","DOI":"10.1074\/jbc.M508780200","volume":"280","author":"SE Wahrle","year":"2005","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Hartman RE, Bales KR, Paul SM, Holtzman DM (2005) Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem 280:43236\u201343242","journal-title":"J Biol Chem"},{"key":"9627_CR35","first-page":"671","volume":"118","author":"SE Wahrle","year":"2008","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, Jain S, Hirsch-Reinshagen V, Wellington CL, Bales KR, Paul SM, Holtzman DM (2008) Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest 118:671\u2013682","journal-title":"J Clin Invest"},{"key":"9627_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/alzrt187","volume":"5","author":"KR Wildsmith","year":"2013","unstructured":"Wildsmith KR, Holley M, Savage JC, Skerrett R, Landreth GE (2013) Evidence for impaired amyloid beta clearance in Alzheimer\u2019s disease. Alzheimers Res Ther 5:33","journal-title":"Alzheimers Res Ther"},{"key":"9627_CR37","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1073\/pnas.0701096104","volume":"104","author":"N Zelcer","year":"2007","unstructured":"Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, Tontonoz P (2007) Attenuation of neuroinflammation and Alzheimer\u2019s disease pathology by liver x receptors. Proc Natl Acad Sci U S A 104:10601\u201310606","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-015-9627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-015-9627-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-015-9627-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T01:56:27Z","timestamp":1566957387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-015-9627-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,15]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["9627"],"URL":"https:\/\/doi.org\/10.1007\/s11481-015-9627-8","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,15]]}}}